Cargando…
A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships
While progress has been made in fighting diseases disproportionally affecting underserved populations, unmet medical needs persist for many neglected tropical diseases. The World Health Organization has encouraged strong public-private partnerships to address this issue and several public and privat...
Autores principales: | Goethals, Olivia, Voge, Natalia V., Kesteleyn, Bart, Chaltin, Patrick, Jinks, Tim, De Marez, Tine, Koul, Anil, Draghia-Akli, Ruxandra, Neyts, Johan, Van Loock, Marnix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902276/ https://www.ncbi.nlm.nih.gov/pubmed/36567021 http://dx.doi.org/10.1016/j.antiviral.2022.105495 |
Ejemplares similares
-
Opportunities for vaccine research in Europe
por: Gancberg, David, et al.
Publicado: (2015) -
The selection of experts evaluating health projects for the EU Sixth Framework Program
por: Quaglio, GianLuca, et al.
Publicado: (2011) -
Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers
por: Ackaert, Oliver, et al.
Publicado: (2023) -
Gene therapy by electroporation for the treatment of chronic renal failure in companion animals
por: Brown, Patricia A, et al.
Publicado: (2009) -
Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)